Beta Drugs
21 December, 2024 22:48 BSE: 531481
NSE: BETAISIN: INE351Y01019
Start SIP in Beta Drugs
Start SIPBeta Drugs Performance
Day Range
52 Week Range
Beta Drugs Technicals
EMA & SMA
Current Price
₹2,060.05
-66.95 (-3.15%)
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹2,138.12
- 50 Day
- ₹2,028.23
- 100 Day
- ₹1,849.96
- 200 Day
- ₹1,628.44
- 20 Day
- ₹2,182.61
- 50 Day
- ₹2,029.86
- 100 Day
- ₹1,798.92
- 200 Day
- ₹1,527.76
Beta Drugs Resistance and Support
PIVOT
₹2,079.34
| Resistance | |
|---|---|
| First Resistance | 2,107.67 |
| Second Resistance | 2,155.28 |
| Third Resistance | 2,183.62 |
| RSI | 44.27 |
| MFI | 36.64 |
| MACD Single Line | 48.18 |
| MACD | 20.97 |
| Support | |
|---|---|
| First Support | 2,031.72 |
| Second Support | 2,003.38 |
| Third Supoort | 1,955.77 |
Beta Drugs Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 2,800 | 190,008 | 67.86 |
| Week | 3,480 | 240,016 | 68.97 |
| 1 Month | 5,241 | 351,822 | 67.13 |
| 6 Month | 7,021 | 499,951 | 71.21 |
Beta Drugs Result Highlights
Beta Drugs Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Beta Drugs Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-11-06 | Quarterly Results | |
| 2024-10-19 | To consider Fund Raising | |
| 2024-05-14 | Audited Results | |
| 2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
| 2023-05-08 | Audited Results |